siRNA Therapeutics for Primary Hyperoxaluria: A Beginning
Mol Ther
.
2016 Apr;24(4):666-7.
doi: 10.1038/mt.2016.50.
Author
Dawn S Milliner
1
Affiliation
1
Division of Nephrology, Departments of Pediatrics and Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
PMID:
27081720
PMCID:
PMC4886951
DOI:
10.1038/mt.2016.50
No abstract available
Publication types
Comment
MeSH terms
Humans
Hyperoxaluria, Primary / genetics*
Kidney Failure, Chronic
Kidney Transplantation
RNA, Small Interfering*
Substances
RNA, Small Interfering
Grants and funding
U54 DK083908/DK/NIDDK NIH HHS/United States